Cite
MLA Citation
G V Long et al.. “Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study.” Annals of oncology, vol. 30, 2019, p. 1848. http://access.bl.uk/ark:/81055/vdc_100098456133.0x00003a